Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

SOX9 is essential for the development of various organs and hair follicles.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Certain genetic variants may increase the risk of developing PCOS.

PCOS is managed by lifestyle changes and personalized medication to improve symptoms and fertility.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

High levels of Anti-Müllerian Hormone (AMH) in the blood can strongly predict Polycystic Ovarian Syndrome (PCOS) and related issues in women of reproductive age.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

AMH is a promising biomarker for diagnosing PCOS.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

AMH is a reliable marker for diagnosing PCOS.

AMH levels in adolescents with PCOS are not affected by their weight.

Serum AMH is a useful biomarker for diagnosing PCOS.

AMH and ovarian morphology help diagnose and understand PCOS more precisely.

Serum AMH levels are a strong marker for diagnosing PCOS in Indian women.

Laparoscopic ovarian drilling helps infertile women with PCOS by improving menstrual regularity, ovulation, and chances of conception, and by changing hormone levels.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Male hormones and their interactions are crucial for male sexual development and characteristics.

Ovarian volume is significantly related to higher levels of certain hormones in Korean women with PCOS.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Women with PCOS have different hormone levels than those without it.

Diagnose PCOS in teens using irregular periods and high androgen levels, not ultrasound.